US 10730834
Dual function molecules for histone deacetylase inhibition and ataxia telangiectasia mutated activation and methods of use thereof
granted A61KA61K2300/00A61K31/404
Quick answer
US patent 10730834 (Dual function molecules for histone deacetylase inhibition and ataxia telangiectasia mutated activation and methods of use thereof) held by Shuttle Pharmaceuticals, Inc. expires Mon Jul 30 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Shuttle Pharmaceuticals, Inc.
- Grant date
- Tue Aug 04 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jul 30 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 10
- CPC classes
- A61K, A61K2300/00, A61K31/404, A61K31/573, A61K45/06